Left ventricular dysfunction in early E. coli endotoxemia: effects of naloxone

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Sepsis Research

Background:

• Opiate receptor antagonist naloxone (NAL) has shown potential in improving cardiac function during circulatory shock.
• The specific impact of NAL on intrinsic cardiac mechanical function during hypodynamic states, particularly in early endotoxemia, remains unclear.

Purpose of the Study:

• To investigate the effects of in vivo naloxone on the contraction-relaxation properties of isolated left ventricular (LV) preparations.
• To determine the influence of NAL on cardiac function 4 hours after the induction of gram-negative endotoxemia.

Main Methods:

• Guinea pigs were administered Escherichia coli endotoxin followed by intravenous treatment with either NAL or saline.
• Isolated, coronary-perfused isovolumic left ventricular (LV) preparations were used to assess mechanical function.
• Measurements included LV systolic pressure and end-diastolic pressure-volume relationships to evaluate contractility and compliance.

Main Results:

• Endotoxemia significantly reduced LV contractile function, an effect not altered by NAL therapy.
• Endotoxin exposure led to decreased diastolic compliance in LV preparations, indicated by altered pressure-volume relationships.
• In vivo NAL administration effectively prevented the endotoxin-induced decrease in LV diastolic compliance.

Conclusions:

• Early (4-hour) non-hypotensive endotoxemia in guinea pigs is associated with both diminished LV contractility and decreased diastolic compliance.
• Naloxone therapy specifically mitigated the reduction in diastolic compliance, suggesting a role for endogenous opioid systems in this aspect of endotoxemia.
• The findings indicate that while NAL does not restore contractility, it may modulate specific cardiac mechanical deficits in early sepsis.